drugset
drugset / Trial / NCT04965402

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants

NCT04965402 ↗

Phase 1 Completed 23 enrolled Bristol-Myers Squibb
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability, drug levels, and drug effects of BMS-986166 in healthy Japanese male and female participants of non-childbearing potential.

Timeline

Start
2021-07-15
Primary completion
2022-02-07
Completion
2022-02-07

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986166 Small molecule — —

Indications

No indication recorded.